摘要
背景:自首次分离抗菌肽(AMPs)以来,它们引起了人们对药物化学的广泛兴趣。然而,目前市场上只有少数基于AMP的药物可用。尽管与常规抗生素相比,AMP的有效性,生物降解性和通用作用模式不太可能诱导抗性,但是它们存在需要解决的主要问题以扩大其使用范围。值得注意的是,AMP缺乏选择性,导致副作用和细胞毒性,并且还表现出体内不稳定性。正在积极考虑几种策略来克服限制AMP成功的局限性。 方法:在目前的工作中,调查了最近报道的在药物设计和分娩方面改善AMP的策略,并评估了它们对患者和环境可能产生的影响。 结果:作为主要优势,AMP具有易于调节的骨架,提供改善其性能的机会。已经报道了在稳定性方面的策略性结构修饰和环状或分支AMP的有益特性。还探索了AMP与纳米颗粒的缀合以增加其体内稳定性。其他技术如AMP与特异性抗体的偶联旨在增加潜在药物对靶标的选择性。评估了这些策略对突出绿色技术的环境的影响。 结论:虽然需要进一步研究,同时考虑到新型AMP的环境和人类健康后果,但其中一些化合物是可持续药物的候选药物。
关键词: 抗菌肽,药物设计,绿色技术,绿色和可持续药物化学,纳米粒子和碳纳米管,结构修饰,拟肽,有机氟
Current Medicinal Chemistry
Title:Recent Advances in the Development of Antimicrobial Peptides (AMPs): Attempts for Sustainable Medicine?
Volume: 25 Issue: 21
关键词: 抗菌肽,药物设计,绿色技术,绿色和可持续药物化学,纳米粒子和碳纳米管,结构修饰,拟肽,有机氟
摘要: Background: Since the first isolation of antimicrobial peptides (AMPs) they have attracted extensive interest in medicinal chemistry. However, only a few AMP-based drugs are currently available on the market. Despite their effectiveness, biodegradability, and versatile mode of action that is less likely to induce resistance compared to conventional antibiotics, AMPs suffer from major issues that need to be addressed to broaden their use. Notably, AMPs can lack selectivity leading to side effects and cytotoxicity, and also exhibit in vivo instability. Several strategies are being actively considered to overcome the limitations that restrain the success of AMPs.
Methods: In the current work, recent strategies reported for improving AMPs in the context of drug design and delivery were surveyed, and also their possible impact on patients and the environment was assessed.
Results: As a major advantage AMPs possess an easily tunable skeleton offering opportunities to improve their properties. Strategic structural modifications and the beneficial properties of cyclic or branched AMPs in term of stability have been reported. The conjugation of AMPs with nanoparticles has also been explored to increase their in vivo stability. Other techniques such as the coupling of AMPs with specific antibodies aim to increase the selectivity of the potential drug towards the target. These strategies were evaluated for their effect on the environment highlighting green technologies.
Conclusion: Although further research is needed taking into account both environmental and human health consequences of novel AMPs, several of these compounds are promising drug candidates for use in sustainable medicine.
Export Options
About this article
Cite this article as:
Recent Advances in the Development of Antimicrobial Peptides (AMPs): Attempts for Sustainable Medicine?, Current Medicinal Chemistry 2018; 25 (21) . https://dx.doi.org/10.2174/0929867325666180117142142
DOI https://dx.doi.org/10.2174/0929867325666180117142142 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Developments in Systemic Therapy for Hepatocellular Carcinoma
Current Cancer Therapy Reviews Epigenetic Mismatches with Mutated Transcribing Genes at Leukemogenic S-Phase Binding/Start Sites – Potential Targets for Therapy with Enzyme Inhibitors
Current Stem Cell Research & Therapy Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology A Closer Look to Polyesters: Properties, Synthesis, Characterization, and Particle Drug Delivery Applications
Nanoscience & Nanotechnology-Asia Treatment of PSA only Recurrence of Prostate Cancer After Prior Local Therapy
Current Pharmaceutical Design The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism Hypertension and Ischemic Heart Disease in Women
Current Pharmaceutical Design Efficacy of Yun Zhi (Coriolus versicolor) on Survival in Cancer Patients: Systematic Review and Meta-Analysis
Recent Patents on Inflammation & Allergy Drug Discovery Aptamers Against Cell Surface Receptors: Selection, Modification and Application
Current Medicinal Chemistry Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms
Endocrine, Metabolic & Immune Disorders - Drug Targets Food-Derived Peptides and Intestinal Functions
Current Pharmaceutical Design Disorders of Mineral Metabolism in the Newborn
Current Pediatric Reviews The Role of HTS in Drug Discovery at the University of Michigan
Combinatorial Chemistry & High Throughput Screening Therapeutic Approaches of Leptin in Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Current Drug Targets Genomics of Addiction
Current Psychiatry Reviews Protein Modification by β-N-Acetyl Glucosamine (O-GlcNAc) in Insulin Signaling and Insulin Resistance
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) New Perspectives on Acetaminophen
Current Cardiology Reviews Chronic Inflammation in the Pancreas and Salivary Glands - Lessons from Similarities and Differences in Pathophysiology and Treatment Modalities
Current Pharmaceutical Design The Role of miRNAs in Plasma Cell Dyscrasias
MicroRNA